CD14 and neoplasm: From our observations we conclude that combined expression of CD14, BDCA3, DC-SIGN, CD16, and CD163 provides a phenotypic profile useful for the identification of M2-macrophage-like subsets with immune-suppressive and tumor-promoting characteristics that arise during tumor-conditioned differentiation or maturation of human DCs.